Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seborrheic Dermatitis”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Not applicableStudy completedNCT06578962
What this trial is testing

Efficacy of a Cosmetic Shampoo RV3438G in Reccurent Squamous States

Who this might be right for
Dermatitis, Seborrheic
Pierre Fabre Dermo Cosmetique 63
Not applicableStudy completedNCT04925180
What this trial is testing

Learn About the Awareness and Knowledge That Doctors Have About the Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Treatments in Europe

Who this might be right for
Signs of Androgenisation in Women, e.g. Hirsutism, Androgenetic Alopecia, Acne and SeborrheaHypersexuality in MenSexual Deviations in Men+1 more
Bayer 600
Post-approval studies (Phase 4)Study completedNCT03567980
What this trial is testing

A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis

Who this might be right for
Seborrheic Dermatitis
University of Alabama at Birmingham 30
Not applicableStudy completedNCT04472546
What this trial is testing

Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory Dermatosis

Who this might be right for
AcneAtopic DermatitisPsoriasis Vulgaris+3 more
Pierre Fabre Dermo Cosmetique 210
Testing effectiveness (Phase 2)UnknownNCT03688971
What this trial is testing

Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis

Who this might be right for
Seborrheic Dermatitis
Maruho Co., Ltd. 36
Testing effectiveness (Phase 2)Study completedNCT04091646
What this trial is testing

Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

Who this might be right for
Seborrheic Dermatitis
Arcutis Biotherapeutics, Inc. 226
Not applicableStudy completedNCT07576023
What this trial is testing

A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in Subjects With Seborrheic Dermatitis

Who this might be right for
Seborrheic Dermatitis
Pierre Fabre Dermo Cosmetique 90
Very early researchLooking for participantsNCT07734441
What this trial is testing

The Effectiveness of Itraconazole Pulse Therapy vs Topical 2% Ketoconazole in the Treatment of Moderate to Severe Seborrheic Dermatitis of Scalp.

Who this might be right for
Seborrheic Dermatitis
Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan 80
Not applicableEnded earlyNCT05319444
What this trial is testing

Cleansing Device for the Treatment of Scalp and Hair Conditions

Who this might be right for
DandruffSeborrheic DermatitisHair Loss
University of Minnesota 2
Not applicableStudy completedNCT07526870
What this trial is testing

Intradermal Microbotulinum Toxin for Sebum Reduction and Facial Pore Improvement

Who this might be right for
Facial AgingFacial Wrinkles and Rhytides Reduction
Instituto de Oftalmología Fundación Conde de Valenciana 30
Early research (Phase 1)Looking for participantsNCT07404033
What this trial is testing

ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patients With Mild to Moderate Seborrheic Dermatitis

Who this might be right for
Seborrheic Dermatitis
Sinomune Pharmaceutical Co., Ltd 48
Large-scale testing (Phase 3)Study completedNCT04973228
What this trial is testing

Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)

Who this might be right for
Seborrheic Dermatitis
Arcutis Biotherapeutics, Inc. 457
Not applicableStudy completedNCT02349854
What this trial is testing

Neurobiology of the Scalp in Seborrheic Dermatitis

Who this might be right for
Seborrheic Dermatitis
Boston University 32
Testing effectiveness (Phase 2)Study completedNCT00403559
What this trial is testing

A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis

Who this might be right for
Seborrheic Dermatitis
Dermatology Specialists Research 113
Not applicableStudy completedNCT07559617
What this trial is testing

Ozonated Oil Emulsion for Seborrhea in Women

Who this might be right for
Cosmetic Management of Oily Scalp
Chadi Khatib 66
Not applicableUnknownNCT01196468
What this trial is testing

HIV Indicator Diseases Survey Across Europe - UK Arm

Who this might be right for
HIVAIDSIndicator Diseases/Indicator Conditions
Chelsea and Westminster NHS Foundation Trust 2,000
Not applicableStudy completedNCT01203189
What this trial is testing

Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo

Who this might be right for
Seborrheic Dermatitis
St. Louis University 23
Not applicableStudy completedNCT04057950
What this trial is testing

Effects on the Scalp Microbiota of a 1% Selenium Disulfide and 1% Salicylic Acid Shampoo After 2% Ketaconazole Foaming Gel Treatment for Scalp Seborrheic Dermatitis

Who this might be right for
Scalp DermatitisDermatitis
L'Oreal 80
Large-scale testing (Phase 3)Study completedNCT02004860
What this trial is testing

Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis

Who this might be right for
Severe Seborrheic Dermatitis
University Hospital, Rouen 120
Early research (Phase 1)UnknownNCT00767546
What this trial is testing

Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients

Who this might be right for
Parkinson DiseaseParkinsonismSeborrheic Dermatitis
Rabin Medical Center 40
Next Page